Carlsmed (CARL) Net Cash Flow (2024 - 2026)

Carlsmed has reported Net Cash Flow for 3 years, with the latest figure at -$12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 486.36% year-over-year to -$12.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.6 million (up 459.88% YoY), and the FY2025 full-year result was $45.7 million, up 39.01% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$12.8 million, up from -$29.6 million in the prior quarter.
• The five-year high for Net Cash Flow was $81.9 million in Q3 2025, with the low at -$29.6 million in Q4 2025.
• Historically, Net Cash Flow has averaged $5.0 million across 3 years, with a median of -$4.3 million in 2024.
• The largest YoY upside for Net Cash Flow was 1201.67% in 2025 against a maximum downside of 585.52% in 2025.
• Carlsmed's Net Cash Flow stood at -$4.3 million in 2024, then tumbled by 585.52% to -$29.6 million in 2025, then jumped by 56.81% to -$12.8 million in 2026.
• The last three Net Cash Flow figures came in at -$12.8 million (Q1 2026), -$29.6 million (Q4 2025), and $81.9 million (Q3 2025), per Business Quant data.